Literature DB >> 168931

A vascular permeability factor in lymphocyte culture supernants from patients with nephrotic syndrome. II. Pharmacological and physicochemical properties.

G Lagrue, A Branellec, C Blanc, S Xheneumont, F Beaudoux, A Sobel, B Weil.   

Abstract

Pharmacological properties of the "Skin Reactive Factor" demonstrated in nephrotic patients are similar to guinea-pig Skin Reactive Factor. This biological activity is not antagonized by anti-histaminic and anti-serotonin drugs. It is inhibited by meclofenamate and pyridinolcanbamate. It is enhanced by diethyldithiocarbamate and normal human serum. According to this results it could be an activator of the kinin system. Biochemical studies indicate that it is a pepsin destroyed protein, unaffected by Rnase and Dnase. Its electrophoretic mobility is that of an albumin or an alpha1 globulin.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 168931

Source DB:  PubMed          Journal:  Biomedicine        ISSN: 0300-0893


  10 in total

1.  Proteinuria: is it all in the foot?

Authors:  Pierre Ronco
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

Review 2.  The role of the immune system in idiopathic nephrotic syndrome: a review of clinical and experimental studies.

Authors:  Wagner de Fátima Pereira; Gustavo Eustáquio Alvim Brito-Melo; Fábio Tadeu Lourenço Guimarães; Thiago Guimarães Rosa Carvalho; Elvis Cueva Mateo; Ana Cristina Simões e Silva
Journal:  Inflamm Res       Date:  2014-01       Impact factor: 4.575

Review 3.  Do circulating factors play a role in the pathogenesis of minimal change nephrotic syndrome?

Authors:  W W Bakker; W H van Luijk
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

Review 4.  The immune system in minimal change nephrotic syndrome.

Authors:  H W Schnaper
Journal:  Pediatr Nephrol       Date:  1989-01       Impact factor: 3.714

5.  Nephrotic syndrome of childhood: malaria therapy reconsidered.

Authors:  T M Barratt
Journal:  Arch Dis Child       Date:  1979-11       Impact factor: 3.791

Review 6.  Cellular immunity in glomerulonephritis.

Authors:  H M Fillit; J B Zabriskie
Journal:  Am J Pathol       Date:  1982-11       Impact factor: 4.307

Review 7.  Rituximab: is replacement of cyclophosphamide and calcineurin inhibitors in steroid-dependent nephrotic syndrome possible?

Authors:  Jörg Dötsch; Dirk E Müller-Wiefel; Markus J Kemper
Journal:  Pediatr Nephrol       Date:  2007-09-26       Impact factor: 3.714

Review 8.  Nephrotic Syndrome: Oedema Formation and Its Treatment With Diuretics.

Authors:  Sanjana Gupta; Ruth J Pepper; Neil Ashman; Stephen B Walsh
Journal:  Front Physiol       Date:  2019-01-15       Impact factor: 4.566

9.  Pre-emptive rituximab in focal and segmental glomerulosclerosis patients at risk of recurrence after kidney transplantation.

Authors:  Pilar Auñón; Natalia Polanco; María José Pérez-Sáez; Emilio Rodrigo; Asunción Sancho; Julio Pascual; Amado Andrés; Manuel Praga
Journal:  Clin Kidney J       Date:  2019-10-03

Review 10.  Permeability factors in nephrotic syndrome and focal segmental glomerulosclerosis.

Authors:  Virginia J Savin; Ellen T McCarthy; Mukut Sharma
Journal:  Kidney Res Clin Pract       Date:  2012-10-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.